Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20131966Phase 2Active
A Phase 2 trial of miglitol in type 2 diabetes mellitus (T2DM), sponsored by Shandong Chengchuang Pharmaceutical Technology Development. Started Mar 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20131966.